Maddie Meyer/Getty Images News
Moderna (MRNA) saw one of the most dramatic single-day moves in the company’s history on positive results for its mRNA cancer vaccine developed with Merck (MRK),
And the stock’s rally of more than 175% reverberated through the options chain.
